Search results
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 weeks agoArbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript May 2, 2024 Arbutus...
Is Arbutus Biopharma (NASDAQ:ABUS) In A Good Position To Deliver On Growth Plans?
Simply Wall St. via Yahoo Finance· 2 months agoEven when a business is losing money, it's possible for shareholders to make money if they buy a...
Institutions own 30% of Arbutus Biopharma Corporation (NASDAQ:ABUS) shares but individual investors...
Simply Wall St. via Yahoo Finance· 5 months agoKey Insights Significant control over Arbutus Biopharma by individual investors implies that the...
Arbutus Biopharma Corporation's (NASDAQ:ABUS) Share Price Could Signal Some Risk
Simply Wall St. via Yahoo Finance· 1 year agoWith a median price-to-sales (or "P/S") ratio of close to 11.8x in the Biotechs industry in the...
Arbutus Biopharma Corporation (NASDAQ:ABUS) has caught the attention of institutional investors who...
Simply Wall St. via Yahoo Finance· 10 months agoKey Insights Institutions' substantial holdings in Arbutus Biopharma implies that they have...
Arbutus Biopharma Corporation (NASDAQ:ABUS) Consensus Forecasts Have Become A Little Darker Since...
Simply Wall St. via Yahoo Finance· 3 months agoArbutus Biopharma Corporation (NASDAQ:ABUS) shareholders are probably feeling a little disappointed,...
Here's Why We're Watching Arbutus Biopharma's (NASDAQ:ABUS) Cash Burn Situation
Simply Wall St. via Yahoo Finance· 1 year agoWe can readily understand why investors are attracted to unprofitable companies. For example,...
Arbutus Biopharma (ABUS) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoAt this time, I would like to welcome everyone to the Arbutus Biopharma 2022 second quarter...
The past three years for Arbutus Biopharma (NASDAQ:ABUS) investors has not been profitable
Simply Wall St. via Yahoo Finance· 4 months agoArbutus Biopharma Corporation (NASDAQ:ABUS) shareholders should be happy to see the share price up...
We Think Arbutus Biopharma (NASDAQ:ABUS) Can Easily Afford To Drive Business Growth
Simply Wall St. via Yahoo Finance· 2 years agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...